| Report ID | 246697 |
| Drug Identification Number | 02421623 |
| Brand name | JAMP-ZOLMITRIPTAN |
| Common or Proper name | Zolmitriptan Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLMITRIPTAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1x6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-23 |
| Estimated end date | 2026-02-28 |
| Actual end date | 2026-01-15 |
| Shortage status | Resolved |
| Updated date | 2026-01-27 |
| Company comments | Allocation - Increase in demand |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2025-01-03 | English | Compare |